RE: NONMEM 7 Update
ICON Development Solutions has made a considerable financial investment in
the major recoding of NONMEM done for version 7. As a commercial entity, it
believes it should protect the intellectual property via encryption while
still allowing the user to make minor adjustments to the installation.
Bill
_____
Quoted reply history
From: [email protected] [mailto:[email protected]] On
Behalf Of Eleveld, DJ
Sent: Thursday, July 02, 2009 6:11 AM
To: Ludden, Thomas; [email protected]
Subject: RE: [NMusers] NONMEM 7 Update
Can anyone explain what advantages encryted source code might have?
For me at least, the NONMEM source code is already functionally encrypted
because of my poor understanding of Fortran. But it is unclear to me what
problem encryted source code actually solves. Can anyone enlighten me?
Douglas Eleveld
_____
From: [email protected] on behalf of Ludden, Thomas
Sent: Wed 01/07/2009 9:21 PM
To: [email protected]
Subject: [NMusers] NONMEM 7 Update
Dear All:
This is just a brief update regarding the availability of NONMEM 7. We had
hoped to begin distribution of this new version at this time. However,
there are some final code changes to be made followed by thorough testing.
We hope to be able to begin distribution in early August.
Please be certain that the contact information that we have on file for your
license(s) is up to date. This is the person to whom NONMEM 7 will be sent
. Please send any updates regarding the correct contact person to
<mailto:[email protected]> [email protected].
Please note that NONMEM 7 will have a licensing system. More details will
be provided as we approach the release date.
Our experience with distributing binary code to the beta testers was very
mixed. Some testers had no problems; others had considerable difficulty
with achieving a successful installation. We are now considering the
distribution of NONMEM 7, for the most part, as encrypted source code. An
installation program will be included. The SIZES file and several other
resource files will be left unencrypted so that the user can make desired
changes prior to compilation as was possible with previous versions. This
change in our method of distribution will require that a revised licensing
agreement be executed.
Regards,
Bob Bauer
Vice-President, Pharmacometrics
Alison Boeckmann
Consultant
Bill Bachman
Director, Pharmacometrics R&D
Tom Ludden
Vice-President, Pharmacometrics R&D
ICON Development Solutions
Tel: + 1 410 696 3040
Mob: + 1 410 258 2411
Fax: + 1 410 480 0776
Email: [email protected]
Web: www.icondevsolutions.com